e.g. mhealth
Search Results (1 to 10 of 26 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 11 JMIR Aging
- 5 Journal of Medical Internet Research
- 4 JMIR Research Protocols
- 2 JMIR Medical Informatics
- 1 Interactive Journal of Medical Research
- 1 JMIR Formative Research
- 1 JMIR Neurotechnology
- 1 JMIR Serious Games
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

Neurodegenerative conditions such as Alzheimer disease (AD) and related dementias precipitate accelerated cognitive deterioration, markedly impacting patients’ daily lives and social engagement [1]. Current estimates suggest that approximately 50 million individuals worldwide suffer from dementia, with this number expected to soar to 152 million by 2050 [2]. Generally, patients diagnosed with mild cognitive impairment (MCI) are at a much higher risk of developing dementia [3].
JMIR Med Inform 2025;13:e60250
Download Citation: END BibTex RIS

Reference 34: Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation Reference 35: A benefit-finding intervention for family caregivers of persons with Alzheimer disease: Reference 37: Long-term outcomes of the benefit-finding group intervention for Alzheimer family caregivers Reference 38: Benefit-finding intervention delivered individually to Alzheimer family caregivers: longer-termalzheimer
JMIR Aging 2025;8:e63715
Download Citation: END BibTex RIS

Reference 2: World Alzheimer Report 2018: the state of the art of dementia research(https://www.alzint.orgalzheimer
JMIR Aging 2024;7:e62689
Download Citation: END BibTex RIS

Early detection of MCI is important for optimizing patient care, potentially enabling the timely use of disease-modifying therapies to prevent Alzheimer disease (AD) and related dementia [4]. As the life expectancy of patients with AD is approximately 8-10 years after symptom onset, preventing disease progression at an early stage is crucial [3].
JMIR Med Inform 2024;12:e59396
Download Citation: END BibTex RIS

Subtle decline in everyday function occurs as part of the normal aging process and as a symptom of pathologies commonly found among older adults, such as Alzheimer disease and related disorders. Likewise, stress from caregiving for older adults with chronic health conditions impacts everyday routines and behaviors such as sleep and physical activity.
J Med Internet Res 2024;26:e54709
Download Citation: END BibTex RIS

Prior studies have reported speech and language declines across disease progression from early MCI to moderate-stage Alzheimer disease [6-8]. Mueller et al [8] found that subtle declines in speech fluency and semantic content are apparent even prior to the onset of clinically diagnosed MCI. Therefore, developing techniques to identify early changes in language functioning may enhance the detection of subtle cognitive decline associated with pathological cognitive aging.
JMIR Aging 2024;7:e54655
Download Citation: END BibTex RIS

In the presence of disease, for example, a neurodegenerative disease such as Alzheimer disease, cognitive reserve is engaged to sustain function for as long as possible and minimize symptoms and disability. Thus, individuals with more cognitive reserve manifest symptoms or disability later than those with lower cognitive reserve; symptoms are less prominent or severe than might be expected for a given amount of pathology.
J Med Internet Res 2024;26:e49794
Download Citation: END BibTex RIS

Adults aged 50 years or older with cognitive impairment including (but not limited to) dementia, Wernicke encephalopathy, delirium, amnestic, Alzheimer disease, organic brain disease or syndrome, benign senescent forgetfulness, Binswanger, Korsakoff syndrome, stroke-related cognitive impairment, Wilhelmsen-Lynch disease, aphasia, Benson syndrome, Huntington's disease, mild cognitive impairment or disorder, Creutzfeldt Jacob disease, or Parkinson disease
The populations cannot be at risk for cognitive impairment
JMIR Neurotech 2024;3:e53038
Download Citation: END BibTex RIS

The prevalence of Alzheimer disease and related dementias (ADRDs) among the Hispanic and Latinx populations is 1.5 times higher than among non-Hispanic White populations [1]. Hispanic and Latinx adults exhibit an earlier onset of ADRDs and more severe symptoms at the time of diagnosis than other ethnic and racial groups [2,3].
JMIR Res Protoc 2024;13:e55216
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section